Editas Medicine (EDIT) Operating Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Operating Expenses data on file, last reported at $32.1 million in Q3 2025.

• On a quarterly basis, Operating Expenses fell 51.18% year-over-year to $32.1 million in Q3 2025; TTM through Dec 2025 was $168.0 million, a 40.72% decrease from a year earlier, with the FY2024 full-year figure at $283.5 million, up 14.62% from the prior year.
• Operating Expenses for Q3 2025 stood at $32.1 million, down from $55.1 million in the prior quarter.
• Over the last five years, Operating Expenses for EDIT reached as high as $84.0 million in Q4 2023 and fell as low as $32.1 million in Q3 2025.
• Historically, Operating Expenses has averaged $61.2 million across 5 years, with a median of $60.6 million in 2022.
• Across the five-year window, Operating Expenses surged 54.14% in 2024 and tumbled 51.18% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $54.1 million in 2021, then advanced by 29.41% to $70.0 million in 2022, then advanced by 20.05% to $84.0 million in 2023, then dropped by 8.11% to $77.2 million in 2024, then plunged by 58.43% to $32.1 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were $32.1 million in Q3 2025, $55.1 million in Q2 2025, and $80.8 million in Q1 2025.